Eledon Pharmaceuticals, Inc. (ELDN) NASDAQ
3.53
-0.23(-6.12%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.53
-0.23(-6.12%)
Currency In USD
| Market Cap | 123.57M |
| Enterprise Value | 101.41M |
| P/E Ratio | -5.08 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.95 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.38 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.53 |
| Return On Equity | -0.97 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -82.94M |
| Net Income | -45.62M |
| Diluted EPS | -0.56 |
| Total Cash | 111.09M |
| Total Cash/Share | 0.99 |
| Total Debt | 555,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 8.44 |
| Book Value Per Share | 0.89 |
| 52-Week Change | 15.36 |
| 52-Week High | 4.6 |
| 52-Week Low | 1.35 |
| Moving Average 50 Days | 3.51 |
| Moving Average 200 Days | 2.66 |
| Average Volume | 1.45M |
| Shares Outstanding | 59.95M |
| % Held by Institutions | 56.5 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:18 |
| Last Split Date | October 05, 2020 |